salmeterol 50mcg

DRUG4 trials

Sponsors

GlaxoSmithKline

Conditions

AsthmaPulmonary Disease, Chronic Obstructive

Phase 2

Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients

CompletedNCT00347139

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2006-05-23End: 2007-01-10Updated: 2017-09-14

Investigation Of A New Medication (GW642444) In Asthmatic Patients

CompletedNCT00354874

GlaxoSmithKlineAsthma

Start: 2005-01-31End: 2005-06-30Updated: 2016-09-15

Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients

CompletedNCT00358488

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2006-04-30End: 2007-01-31Updated: 2016-10-28

Phase 4

Chronic Obstructive Pulmonary Disease Endpoints Study

CompletedNCT00358358

GlaxoSmithKlinePulmonary Disease, Chronic Obstructive

Start: 2006-03-31End: 2007-02-28Updated: 2017-01-20

Related Papers

Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD

BMJ Open Respiratory Research2016-09-0142 citations

Minimal effect of inhaled corticosteroids (ICS) on blood eosinophil count in steroid-naïve COPD patients

2015-09-012 citations